Storia della carriera di Ingmar Bruns
Precedenti posizioni note di Ingmar Bruns
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TRILLIUM THERAPEUTICS | Direttore Tecnico/Scientifico/R&S | 02/11/2020 | 17/11/2021 |
| PIERIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 12/10/2017 | - |
Formazione di Ingmar Bruns
| Universität zu Lübeck | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 2 |
| Germania | 2 |
| Canada | 2 |
Posizioni
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- Ingmar Bruns
- Esperienza
